iBio, Inc. - Common Stock, par value $0.001 per share (IBIO)
CUSIP: 451033708
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 30,719,795
- Total 13F shares
- 2,451,117
- Share change
- -433,680
- Total reported value
- $5,171,853
- Price per share
- $2.11
- Number of holders
- 26
- Value change
- -$1,674,085
- Number of buys
- 8
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 451033708?
CUSIP 451033708 identifies IBIO - iBio, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 451033708:
Top shareholders of IBIO - iBio, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. |
13F
|
Company |
2.2%
|
680,000
|
$2,760,800 | — | 31 Mar 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
2%
|
600,000
|
$2,436,000 | — | 31 Mar 2024 | |
| Lynx1 Capital Management LP |
13F
|
Company |
2%
|
600,000
|
$2,436,000 | — | 31 Mar 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
2%
|
600,000
|
$2,192,400 | — | 31 Mar 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
1.1%
|
350,877
|
$1,424,561 | — | 31 Mar 2024 | |
| Randy Joe Maddux |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
271,757
|
$72,151 | — | 07 Dec 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.05%
|
15,879
|
$64,000 | — | 31 Mar 2024 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
14,000
|
$56,840 | — | 31 Mar 2024 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0.03%
|
9,000
|
$36,000 | — | 31 Mar 2024 | |
| Robert Matthew Lutz |
3/4/5
|
Chief Financial & Business Officer and Principal Accounting Officer |
—
class O/S missing
|
102,165
|
$27,125 | — | 11 Nov 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.02%
|
5,815
|
$23,609 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
5,603
|
$22,748 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,877
|
$7,621 | — | 31 Mar 2024 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
1,000
|
$4,060 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
502
|
$2,038 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
268
|
$1,088 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
161
|
$654 | — | 31 Mar 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
161
|
$654 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
58
|
$234 | — | 31 Mar 2024 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0%
|
40
|
$162 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
28
|
$114 | — | 31 Mar 2024 | |
| Retirement Group, LLC |
13F
|
Company |
0%
|
14
|
$57 | — | 31 Mar 2024 | |
| SOA Wealth Advisors, LLC. |
13F
|
Company |
0%
|
13
|
$53 | — | 31 Mar 2024 | |
| CITY HOLDING CO |
13F
|
Company |
0%
|
4
|
$16 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
4
|
$16 | — | 31 Mar 2024 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
3
|
$12 | — | 31 Mar 2024 | |
| Financial Gravity Asset Management, Inc. |
13F
|
Company |
0%
|
4
|
$11 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
2
|
$8 | — | 31 Mar 2024 | |
| Arax Advisory Partners |
13F
|
Company |
0%
|
1
|
$5 | — | 31 Mar 2024 | |
| Thomas F. Isett |
3/4/5
|
CEO and Executive Chairman, Director |
—
class O/S missing
|
2,000,000
|
— | — | 08 Sep 2022 | |
| General Hill (ret) James T. |
3/4/5
|
Director |
—
class O/S missing
|
109,000
|
— | — | 09 Dec 2021 | |
| Glenn Chang |
3/4/5
|
Director |
—
class O/S missing
|
109,000
|
— | — | 09 Dec 2021 | |
| John D. McKey Jr. |
3/4/5
|
Director |
—
class O/S missing
|
109,000
|
— | — | 09 Dec 2021 | |
| Linda Washington Armstrong |
3/4/5
|
Director |
—
class O/S missing
|
109,000
|
— | — | 09 Dec 2021 |
Institutional Holders of iBio, Inc. - Common Stock, par value $0.001 per share (IBIO) as of Q2 2024
As of 30 Jun 2024,
iBio, Inc. - Common Stock, par value $0.001 per share (IBIO) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,451,117 shares.
The largest 10 holders included
Ikarian Capital, LLC, Lynx1 Capital Management LP, ADAR1 Capital Management, LLC, Opaleye Management Inc., BOOTHBAY FUND MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, VANGUARD GROUP INC, NORTHERN TRUST CORP, and BlackRock Inc..
This page lists
26
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
26
Q2 2024 holders
26
Holder diff
0
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.